Related Experiment Videos
Plasma exchange in rhabdomyolysis
J J Cornelissen1, W Haanstra, H J Haarman
1Department of Internal Medicine, University Hospital, Utrecht, The Netherlands.
Intensive Care Medicine
|January 1, 1989
Summary
Plasma exchange (PE) offers limited benefit for rhabdomyolysis patients, causing only a temporary drop in creatinine phosphokinase without preventing kidney failure. Frequent PE treatments are impractical, and given the good prognosis of myoglobinuric renal failure, intensive PE is not recommended.
Area of Science:
- Nephrology
- Intensive Care Medicine
- Biochemistry
Background:
- Rhabdomyolysis is a clinical syndrome characterized by muscle breakdown.
- Myoglobin release into circulation can lead to acute kidney injury.
- Plasma exchange (PE) is a therapeutic apheresis technique that removes plasma components.
Observation:
- This study evaluated the effect of plasma exchange in four patients diagnosed with rhabdomyolysis.
- A single plasma exchange procedure was administered to each patient.
- The study monitored changes in creatinine phosphokinase levels and renal function.
Findings:
- A single plasma exchange treatment resulted in a transient decrease in creatinine phosphokinase levels.
- Plasma exchange did not prevent the onset or progression of renal failure in these patients.
- Theoretical calculations suggest that extremely frequent PE sessions would be necessary to adequately clear myoglobin and other toxins.
Implications:
- Intensive plasma exchange is not recommended as a therapeutic strategy for rhabdomyolysis-induced renal failure.
- The generally favorable prognosis of myoglobinuric renal failure supports conservative management over aggressive apheresis.
- Further research may explore alternative or adjunctive therapies for severe rhabdomyolysis.